Tennor Therap-b
Tennor Therap-b (HKSE: 6872) is trading at HK$120.40, about ₹1,475 at today's HKD/INR rate, as of 25 Sep 2026, 3:59 AM ET, down 2.59% today. Indian residents can buy Tennor Therap-b from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$117.80
Today's high
HK$124.20
52 week low
HK$113.30
52 week high
HK$287.00
6872 opened at HK$123.90, closed previously at HK$123.60, and has traded between HK$113.30 and HK$287.00 over the past 52 weeks.
About
TenNor Therapeutics (Suzhou) Limited specializes in researching, developing, and bringing to market unique therapies for illnesses arising from bacterial infections and bacterial metabolic functions. Its robust product pipeline includes Rifasutenizole (TNP-2198), designed to combat Helicobacter pylori infections. Another key asset, Rifaquizinone (TNP-2092), is being advanced in an injectable formulation to treat Periprosthetic Joint Infection (PJI), Acute Bacterial Skin and Skin Structure Infections (ABSSSI), and infections associated with Left Ventricular Assist Devices (LVADs). An oral variant of TNP-2092 is aimed at addressing conditions linked to gut bacterial metabolism, such as Hepatic Encephalopathy (HE) and Irritable Bowel Syndrome with Diarrhea (IBS-D). Furthermore, their development programs feature a topical TNP-2092 for confronting drug-resistant bacterial strains and biofilm-mediated infections; TNBi-1, a novel narrow-spectrum small molecule for H. pylori; TNBi-2, a broad-spectrum, multi-targeting small molecule for Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD); and TNBm-1, a broad-spectrum bifunctional small molecule for metabolic disorders. The company was established in 2012 and maintains its headquarters in Suzhou, China.
Key statistics
Avg. volume
106.37K
Market cap
HK$6.30B
P/E Ratio
0.00
Price-to-sales ratio
0.00
Enterprise value
CN¥5.23B
Free cash flow yield
-0.62%
Debt-to-equity ratio
0.19
Return on equity
37.65%
ROIC
-26.73%
Beta
7.42
Dividend yield
0.00%
Last dividend
HK$0.00
Financial overview
Revenue
CN¥0.00
Earnings per share
-CN¥2.96
Free cash flow
-CN¥87.65M
Net profit margin
0.00%
Gross margin
0.00%
EBITDA
-CN¥150.18M
Revenue growth
—
How to buy Tennor Therap-b from India
Indian residents can buy Tennor Therap-b shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Tennor Therap-b and place an order
Find Tennor Therap-b by name or by its ticker, 6872, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Tennor Therap-b trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Tennor Therap-b position in HKD and INR. Tennor Therap-b pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Tennor Therap-b from India
Trading and taxes when buying Tennor Therap-b from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneTennor Therap-b does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Tennor Therap-b stock?
Yes. Tennor Therap-b (6872) has been listed on the Hong Kong Stock Exchange since 2026, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Tennor Therap-b share cost in rupees?
One Tennor Therap-b share is HK$120.40 — about ₹1,475 at an HKD/INR rate of 12.25 on 24 Sep 2026. Both the Tennor Therap-b price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Tennor Therap-b from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Tennor Therap-b?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Tennor Therap-b shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Tennor Therap-b price. Paasa issues a capital-gains statement for your return.
Does Tennor Therap-b pay a dividend?
No. Tennor Therap-b does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Tennor Therap-b from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Tennor Therap-b a Hong Kong SAR China company, and does that change how it is taxed?
Tennor Therap-b trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Tennor Therap-b trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Tennor Therap-b shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Tennor Therap-b holding, its cost and its closing value.
How do I sell Tennor Therap-b and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.